allylamine has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Robinson, JG | 1 |
| Wright, WL | 1 |
1 review(s) available for allylamine and Disease Exacerbation
| Article | Year |
|---|---|
LDL reduction: how low should we go and is it safe?
Topics: Allylamine; Anticholesteremic Agents; Azetidines; Cholesterol, LDL; Colesevelam Hydrochloride; Coronary Artery Disease; Disease Progression; Drug Therapy, Combination; Ezetimibe; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Muscular Diseases; Niacin; Risk Factors; Stroke | 2008 |
1 other study(ies) available for allylamine and Disease Exacerbation
| Article | Year |
|---|---|
The management of type 2 diabetes mellitus: a novel approach for addressing glycemic and lipid control with colesevelam HCl.
Topics: Allylamine; Anticholesteremic Agents; Cardiovascular Diseases; Cholesterol, LDL; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Disease Progression; Drug Monitoring; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Hyperlipidemias; Hypoglycemic Agents; Life Style; Practice Guidelines as Topic; Risk Reduction Behavior; Treatment Outcome; United States | 2009 |